Prevalence of anticardiolipin antibodies in type 1 diabetes and autoimmune thyroiditis


Creative Commons License

ABACI A., Bober E., Yesilkaya E., BİDECİ A., CİNAZ P., Buyukgebiz A.

POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, cilt.120, sa.3, ss.71-74, 2010 (SCI-Expanded) identifier identifier identifier

Özet

INTRODUCTION High levels of anticardiolipin (aCL) antibodies may predict vascular complications that could develop in type 1 diabetes and auto-immune thyroiditis (AIT). However, the clinical relevance of these antibodies in subjects with type 1 diabetes and AIT is unclear.